| Q33719810 | A Hyper-Crosslinked Carbohydrate Polymer Scaffold Facilitates Lineage Commitment and Maintains a Reserve Pool of Proliferating Cardiovascular Progenitors |
| Q61449743 | A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function |
| Q90668227 | A Miniaturized, Programmable Pacemaker for Long-Term Studies in the Mouse |
| Q51062814 | A Protocol for Collecting Human Cardiac Tissue for Research. |
| Q91433760 | A mouse model of heart failure exhibiting pulmonary edema and pleural effusion: Useful for testing new drugs |
| Q34669335 | A needleless liquid jet injection delivery method for cardiac gene therapy: a comparative evaluation versus standard routes of delivery reveals enhanced therapeutic retention and cardiac specific gene expression |
| Q39168641 | A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis |
| Q37400718 | A nonthoracotomy myocardial infarction model in an ovine using autologous platelets |
| Q38240412 | A role for membrane shape and information processing in cardiac physiology |
| Q38344723 | Allogeneic cardiac stem cell administration for acute myocardial infarction |
| Q82488628 | Alteration of LV end-diastolic volume by controlling the power of the continuous-flow LVAD, so it is synchronized with cardiac beat: development of a native heart load control system (NHLCS) |
| Q47833650 | An Interposed Pad in Open-Chest Echocardiographic Porcine Scans for Mimicking Ultrasound Signal Attenuation in a Human Chest |
| Q38267810 | An overview on development and application of an experimental platform for quantitative cardiac imaging research in rabbit models of myocardial infarction |
| Q41389933 | Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure |
| Q26865437 | Animal and in silico models for the study of sarcomeric cardiomyopathies |
| Q37974118 | Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing |
| Q26797153 | Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria |
| Q36949129 | Benefits of standardizing the treatment of arrhythmias in the sheep (Ovis aries) model of chronic heart failure after myocardial infarction |
| Q39713637 | Biomechanical Properties and Microstructure of Heart Chambers: A Paired Comparison Study in an Ovine Model |
| Q34479363 | Bovine model of doxorubicin-induced cardiomyopathy |
| Q36822346 | Brain growth of the domestic pig (Sus scrofa) from 2 to 24 weeks of age: a longitudinal MRI study |
| Q28243737 | Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model |
| Q41129527 | Cardiac Myosin Activation with Gene Therapy Produces Sustained Inotropic Effects and May Treat Heart Failure with Reduced Ejection Fraction |
| Q99568295 | Cardiac output improvement by pecavaptan: A novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failure |
| Q34617472 | Cardiac regeneration using pluripotent stem cells--progression to large animal models. |
| Q39310120 | Cardiac stem cells: translation to human studies. |
| Q38546856 | Cardioprotection in ischaemia-reperfusion injury: novel mechanisms and clinical translation |
| Q58478037 | Cardiosphere-derived cells suppress allogeneic lymphocytes by production of PGE2 acting via the EP4 receptor |
| Q57818505 | Cardiovascular disease models: A game changing paradigm in drug discovery and screening |
| Q26779676 | Cardiovascular imaging: what have we learned from animal models? |
| Q37731205 | Challenges in using stem cells for cardiac repair |
| Q45421871 | Change in myocardial oxygen consumption employing continuous-flow LVAD with cardiac beat synchronizing system, in acute ischemic heart failure models |
| Q90405130 | Clinical overview of the HVAD: a centrifugal continuous-flow ventricular assist device with magnetic and hydrodynamic bearings including lateral implantation strategies |
| Q58802723 | Common swine models of cardiovascular disease for research and training |
| Q64997487 | Comprehensive Characterization of Swine Cardiac Troponin T Proteoforms by Top-Down Mass Spectrometry. |
| Q33613128 | Construction of a cDNA library for miniature pig mandibular deciduous molars |
| Q34405482 | Cyclin A2 induces cardiac regeneration after myocardial infarction through cytokinesis of adult cardiomyocytes |
| Q89123147 | Decreased contractility and altered responses to inotropic agents in myocytes from tachypacing-induced heart failure canines |
| Q37731623 | Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest |
| Q30557205 | Development of a closed chest model of chronic myocardial infarction in Swine: magnetic resonance imaging and pathological evaluation |
| Q85937226 | Development of a novel drive mode to prevent aortic insufficiency during continuous-flow LVAD support by synchronizing rotational speed with heartbeat |
| Q35159927 | Development of a preclinical model of ischemic cardiomyopathy in swine |
| Q48612322 | Distinct sequences and post-translational modifications in cardiac atrial and ventricular myosin light chains revealed by top-down mass spectrometry |
| Q89782554 | Dysregulation of Calcium Handling in Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy: Mechanisms and Experimental Therapeutic Strategies |
| Q90169667 | ETV2/ER71 Transcription Factor as a Therapeutic Vehicle for Cardiovascular Disease |
| Q38178645 | Endogenous cardiac stem cells for the treatment of heart failure |
| Q26744575 | Engineered Swine Models of Cancer |
| Q90718914 | Engineering hiPSC cardiomyocyte in vitro model systems for functional and structural assessment |
| Q96955294 | Establishment of adult right ventricle failure in ovine using a graded, animal-specific pulmonary artery constriction model |
| Q38423857 | Extracellular matrix communication and turnover in cardiac physiology and pathology |
| Q36365384 | Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes |
| Q38302660 | Gene reprogramming in exercise-induced cardiac hypertrophy in swine: A transcriptional genomics approach. |
| Q26798712 | Genetics of Human and Canine Dilated Cardiomyopathy |
| Q52581669 | Genome Editing and Induced Pluripotent Stem Cell Technologies for Personalized Study of Cardiovascular Diseases. |
| Q49073906 | Global and regional wall motion abnormalities of pacing-induced heart failure assessed by multi-detector row CT: a patient and canine model study |
| Q90405173 | How to do it: tips and tricks of minimal-invasive HVAD® implantation-the lateral approach |
| Q92663895 | Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform |
| Q34133412 | Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. |
| Q28081697 | Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes |
| Q35849561 | Identification of General and Heart-Specific miRNAs in Sheep (Ovis aries) |
| Q30413268 | Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells |
| Q91867469 | Impaired Baroreflex Function in an Ovine Model of Chronic Heart Failure Induced by Multiple Coronary Microembolizations |
| Q36364300 | In search of new therapeutic targets and strategies for heart failure: recent advances in basic science |
| Q37071104 | In vitro comparison of Doppler and catheter-measured pressure gradients in 3D models of mitral valve calcification |
| Q35957030 | Increasing venoarterial extracorporeal membrane oxygenation flow negatively affects left ventricular performance in a porcine model of cardiogenic shock |
| Q38267844 | Insights into RNA transcriptome profiling of cardiac tissue in obesity and hypertension conditions |
| Q37406111 | Integrating the myocardial matrix into heart failure recognition and management |
| Q35844633 | Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy |
| Q36787202 | Investigation of MMP-2 and MMP-9 activities in canine sera with dilated cardiomyopathy |
| Q53032907 | Ischemia-induced model of diastolic dysfunction in sheep. |
| Q37660159 | Isolated effect of geometry on mitral valve function for in silico model development |
| Q52866940 | Isolation of Pig Bone Marrow-Derived Mesenchymal Stem Cells. |
| Q57578159 | Isolation, Characterization and Differentiation Potential of Cardiac Progenitor Cells in Adult Pigs |
| Q36713333 | Isolation, Characterization, and Spatial Distribution of Cardiac Progenitor Cells in the Sheep Heart |
| Q93048686 | Large Animal Models of Heart Failure With Reduced Ejection Fraction (HFrEF) |
| Q38886473 | Large animal model of functional tricuspid regurgitation in pacing induced end-stage heart failure. |
| Q26766350 | Large animal models of cardiovascular disease |
| Q35587392 | Left ventricular remodeling in swine after myocardial infarction: a transcriptional genomics approach. |
| Q35194787 | Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction |
| Q35396651 | Low-intensity interval exercise training attenuates coronary vascular dysfunction and preserves Ca²⁺-sensitive K⁺ current in miniature swine with LV hypertrophy |
| Q37648508 | M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics |
| Q48704464 | Magnetic resonance imaging of the neonatal piglet brain |
| Q92326034 | Main histological parameters to be evaluated in an experimental model of myocardial infarct treated by stem cells on pigs |
| Q47119099 | Methods To Assess Shear-Thinning Hydrogels for Application As Injectable Biomaterials |
| Q26823061 | Model-specific selection of molecular targets for heart failure gene therapy |
| Q92302079 | Modeling heart failure in animal models for novel drug discovery and development |
| Q36738466 | Models for preclinical studies in aging-related disorders: One is not for all. |
| Q30274835 | Multiparametric CMR imaging of infarct remodeling in a percutaneous reperfused Yucatan mini-pig model |
| Q30362840 | Myocardial fibrosis: biomedical research from bench to bedside. |
| Q36396792 | Neuroanatomy of the Pig Cardiac Ventricles. A Stereomicroscopic, Confocal and Electron Microscope Study |
| Q30811829 | Optimal management of the critically ill: anaesthesia, monitoring, data capture, and point-of-care technological practices in ovine models of critical care |
| Q50968776 | Optimized method for isolating highly purified and functional porcine aortic endothelial and smooth muscle cells. |
| Q38097512 | Perspective and challenges of mesenchymal stem cells for cardiovascular regeneration. |
| Q28534595 | Porcine adipose tissue-derived mesenchymal stem cells retain their proliferative characteristics, senescence, karyotype and plasticity after long-term cryopreservation |
| Q88219970 | Preclinical Studies of Stem Cell Therapy for Heart Disease |
| Q38087578 | Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success |
| Q37232553 | Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction |
| Q47780593 | Prophylactic and therapeutic effects of garlic extract on Nerium oleander-induced arrhythmia: a new approach to antiarrhythmic therapy in an ovine model |
| Q57396450 | Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection Fraction |
| Q33680476 | Proteomics in heart failure: top-down or bottom-up? |
| Q90727956 | Quantitative Proteomic and Phosphoproteomic Profiling of Ischemic Myocardial Stunning in Swine |
| Q35185962 | Real-time cardiac metabolism assessed with hyperpolarized [1-(13) C]acetate in a large-animal model |
| Q37828115 | Recent advances in the use of Sus scrofa (pig) as a model system for proteomic studies |
| Q35586219 | Reference values for echocardiographic parameters and indexes of left ventricular function in healthy, young adult sheep used in translational research: comparison with standardized values in humans |
| Q36510256 | Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model |
| Q49098158 | Response to exercise and mechanical efficiency in non-ischaemic stunning, induced by short-term rapid pacing in dogs: a role for calcium? |
| Q28291290 | S100A1 gene therapy for heart failure: A novel strategy on the verge of clinical trials |
| Q88631526 | Scar Size and Other Parameters for Tracking Left Ventricular Dysfunction after Induction of Myocardial Infarcts in Sheep (Ovisaries) |
| Q36364241 | Sex differences in porcine left ventricular myocardial remodeling due to right ventricular pacing. |
| Q89176614 | Size-Dependent Ability of Liposomes to Accumulate in the Ischemic Myocardium and Protect the Heart |
| Q28658055 | Small and large animal models in cardiac contraction research: advantages and disadvantages |
| Q52649058 | Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine. |
| Q99593598 | Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-MI Remodeling |
| Q37878086 | Targeted gene therapy for the treatment of heart failure |
| Q41829618 | Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction |
| Q26766151 | The cardiac enigma: current conundrums in heart failure research |
| Q64120212 | The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense |
| Q38616615 | The pathophysiology of pulmonary hypertension in left heart disease |
| Q30567453 | The use of gadolinium-carbon nanostructures to magnetically enhance stem cell retention for cellular cardiomyoplasty |
| Q36873848 | The zebrafish as a novel animal model to study the molecular mechanisms of mechano-electrical feedback in the heart |
| Q41890749 | Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model |
| Q34303423 | Top-down proteomics reveals concerted reductions in myofilament and Z-disc protein phosphorylation after acute myocardial infarction |
| Q33728779 | Translation of Cardiac Myosin Activation with 2-deoxy-ATP to Treat Heart Failure via an Experimental Ribonucleotide Reductase-Based Gene Therapy |
| Q37052256 | Translation of Methodology Used In Human Myocardial Imaging to a Sheep Model of Acute Myocardial Infarction |
| Q90267617 | Translational Models of Arrhythmia Mechanisms and Susceptibility: Success and Challenges of Modeling Human Disease |
| Q39447181 | Use of Adeno-Associated Virus Vector for Cardiac Gene Delivery in Large-Animal Surgical Models of Heart Failure |
| Q43499984 | Validation of admittance computed left ventricular volumes against real-time three-dimensional echocardiography in the porcine heart. |
| Q51325083 | What Is the Optimal Setting for a Continuous-Flow Left Ventricular Assist Device in Severe Mitral Regurgitation? |
| Q30560369 | Zebrafish heart failure models for the evaluation of chemical probes and drugs |